Terms: = Thyroid cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Diagnosis
74 results:
1. [Attempt to Evaluate the Influence of Morphology, Blood Flow, and Hardness in Mammary Gland Malignant Disease].
Horita H; Narumi A; Kamada M; Ogasawara K
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2023 Nov; 79(11):1287-1292. PubMed ID: 37839866
[TBL] [Abstract] [Full Text] [Related]
2. A case report of anterior mediastinal signet ring cell carcinoma.
Liu S; Zhao A; Mao M
Medicine (Baltimore); 2022 Dec; 101(48):e32202. PubMed ID: 36482538
[TBL] [Abstract] [Full Text] [Related]
3. Top Ten Tips Palliative Care Clinicians Should Know About Managing Immune-Mediated Endocrine Toxicities in cancer.
Ferreira MN; Rao M; Kamal AH; Shariff A
J Palliat Med; 2022 Nov; 25(11):1715-1720. PubMed ID: 35696238
[TBL] [Abstract] [Full Text] [Related]
4. Systematic Review and Meta-Analysis to Identify the Immunocytochemical Markers Effective in Delineating Benign from Malignant thyroid Lesions in FNAC Samples.
Mohan U; Sunny SP; Mendonca P; Kuriakose MA; Kannan S; Suresh A
Endocr Pathol; 2022 Jun; 33(2):243-256. PubMed ID: 35596875
[TBL] [Abstract] [Full Text] [Related]
5. Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors.
Chennamadhavuni A; Abushahin L; Jin N; Presley CJ; Manne A
Front Immunol; 2022; 13():779691. PubMed ID: 35558065
[TBL] [Abstract] [Full Text] [Related]
6. Fine needle aspiration cytology of primary thyroid non-hodgkins lymphoma: Experience from a tertiary care center of North India.
Singh M; Nain G; Jain S; Singh S; Malhotra V
J Cancer Res Ther; 2022; 18(1):185-189. PubMed ID: 35381782
[TBL] [Abstract] [Full Text] [Related]
7. [Endocrinopathies Associated with Immune Checkpoint Inhibitors].
Santos MJ
Acta Med Port; 2022 Mar; 35(3):209-215. PubMed ID: 35077347
[TBL] [Abstract] [Full Text] [Related]
8. Risk of malignancy in patients with inflammatory bowel disease: A population-based cohort study from China.
Zhang H; Zhang M; Chen X; Guo M; Zhou R; Lv H; Li Y; Tan B; Li J; Xu H; Zheng W; Yang H; Qian J
Int J Cancer; 2022 Jun; 150(11):1770-1778. PubMed ID: 35037241
[TBL] [Abstract] [Full Text] [Related]
9. Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study.
Hribernik N; Huff DT; Studen A; Zevnik K; Klaneček Ž; Emamekhoo H; Škalic K; Jeraj R; Reberšek M
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1857-1869. PubMed ID: 34958422
[TBL] [Abstract] [Full Text] [Related]
10. Characterisation of the onset and severity of adrenal and thyroid dysfunction associated with ctla4-related hypophysitis.
Seejore K; Giannoudi M; Osborn D; Lynch JM; Al-Qaissi A; Dunwoodie E; Hook J; Marples M; Murray RD
Eur J Endocrinol; 2021 Dec; 186(1):83-93. PubMed ID: 34735371
[TBL] [Abstract] [Full Text] [Related]
11. Utility of B-Mode, Color Doppler and Elastography in the diagnosis of Breast cancer: Results of the CD-CONFIRM Multicenter Study of 1351 Breast Solid Masses.
Watanabe T; Yamaguchi T; Okuno T; Konno S; Takaki R; Sato M; Tsuruoka M; Shirai H; Ogawa Y; Ban K; Fujimoto Y; Hirokaga K; Watanabe R; Morita T
Ultrasound Med Biol; 2021 Nov; 47(11):3111-3121. PubMed ID: 34456085
[TBL] [Abstract] [Full Text] [Related]
12. Cardiac Amyloidosis Presenting with Pre-Excitation Syndrome, Heart Failure, and Severe Factor X Deficiency as Part of Systemic Amyloid Light-Chain (AL) Amyloidosis - A Fatal Combination.
Almasri H; Almeer A; Awouda S; Hamid O; Sardar S; Anwer Z; Ibrahim F; Soliman D; Kandathil Y; Abu-Tineh M; Alabdul Razzak I; Alazawi SH
Am J Case Rep; 2021 Aug; 22():e933398. PubMed ID: 34413281
[TBL] [Abstract] [Full Text] [Related]
13. Clinical value of contrast-enhanced ultrasonography in focal hypoechogenic lesions of thyroid.
Liang S; Gao N; Bian D; Zhai Q; Yang P; Huang K
Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):2077-2082. PubMed ID: 34274997
[TBL] [Abstract] [Full Text] [Related]
14. Genetic variants and risk of thyroid cancer among Iranian patients.
Jamshidi M; Farnoosh G; Mohammadi Pour S; Rafiee F; Saeedi Boroujeni A; Mahmoudian-Sani MR
Horm Mol Biol Clin Investig; 2021 Feb; 42(2):223-234. PubMed ID: 33544997
[TBL] [Abstract] [Full Text] [Related]
15. Adult Langerhans cell histiocytosis of skull in a patient with synchronous papillary thyroid carcinoma and Castleman disease.
Kim IK; Lee KY
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33495189
[TBL] [Abstract] [Full Text] [Related]
16. Cytopathologic findings in histiocytic sarcoma of thyroid mimicking as anaplastic carcinoma: A report of a rare case with review of literature.
Gupta D; Gupta A; Nalwa A; Yadav T; Chaudhary R; Rao M
Diagn Cytopathol; 2021 Jun; 49(6):E218-E221. PubMed ID: 33277975
[TBL] [Abstract] [Full Text] [Related]
17. [Endocrine side effects of cancer immunotherapy].
Kroiß M; Schilling B; Deutschbein T
Dtsch Med Wochenschr; 2020 Dec; 145(24):1736-1741. PubMed ID: 33254246
[TBL] [Abstract] [Full Text] [Related]
18. Immune-related adverse events in patients with solid-organ tumours treated with immunotherapy: a 3-year study of 102 cases from a single centre.
Gonzalez-Mazón I; Sánchez-Bilbao L; Martín-Varillas JL; García-Castaño A; Delgado-Ruiz M; Bernat Piña I; Hernández JL; Castañeda S; Llorca J; González-Gay MA; Blanco R
Clin Exp Rheumatol; 2021; 39(3):612-620. PubMed ID: 32896258
[TBL] [Abstract] [Full Text] [Related]
19. Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer.
Crespo-Rodriguez E; Bergerhoff K; Bozhanova G; Foo S; Patin EC; Whittock H; Buus R; Haider S; Muirhead G; Thway K; Newbold K; Coffin RS; Vile RG; Kim D; McLaughlin M; Melcher AA; Harrington KJ; Pedersen M
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32759235
[TBL] [Abstract] [Full Text] [Related]
20. Integrative analysis of key candidate genes and signaling pathways in autoimmune thyroid dysfunction related to anti-ctla-4 therapy by bioinformatics.
Zhang Y; Garofano F; Wu X; Schmid M; Krawitz P; Essler M; Schmidt-Wolf IGH
Invest New Drugs; 2020 Dec; 38(6):1717-1729. PubMed ID: 32500465
[TBL] [Abstract] [Full Text] [Related]
[Next]
